Apimeds Pharmaceuticals US, Inc (APUS) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Drug Manufacturers - Specialty & Generic industria. La empresa tiene su sede en Hopewell, NJ, United States. El CEO actual es Youngjik Cho.
APUS tiene fecha de IPO 2025-05-09, 2 empleados a tiempo completo, cotiza en el American Stock Excha, una capitalización de mercado de $2.36M.
Apimeds Pharmaceuticals US, Inc. operates as a clinical stage biopharmaceutical company in the United States. It researches, develops, manufactures, commercializes, and sells Apitox, an active pharmaceutical ingredient for the treatment of inflammation and pain management symptoms associated with osteoarthritis and multiple sclerosis. The company was incorporated in 2020 and is based in Hopewell, New Jersey. Apimeds Pharmaceuticals US, Inc. is a subsidiary of Api Meds, Inc.
